BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 18524678)

  • 1. Renaissance in antibacterial discovery from actinomycetes.
    Baltz RH
    Curr Opin Pharmacol; 2008 Oct; 8(5):557-63. PubMed ID: 18524678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chapter 5. Applying the genetics of secondary metabolism in model actinomycetes to the discovery of new antibiotics.
    van Wezel GP; McKenzie NL; Nodwell JR
    Methods Enzymol; 2009; 458():117-41. PubMed ID: 19374981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel metabolites from marine actinomycetes.
    Lam KS
    Curr Opin Microbiol; 2006 Jun; 9(3):245-51. PubMed ID: 16675289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marine actinomycetes as an emerging resource for the drug development pipelines.
    Zotchev SB
    J Biotechnol; 2012 Apr; 158(4):168-75. PubMed ID: 21683100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postgenomic strategies in antibacterial drug discovery.
    Brötz-Oesterhelt H; Sass P
    Future Microbiol; 2010 Oct; 5(10):1553-79. PubMed ID: 21073314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New antibiotics from bacterial natural products.
    Clardy J; Fischbach MA; Walsh CT
    Nat Biotechnol; 2006 Dec; 24(12):1541-50. PubMed ID: 17160060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare actinomycetes: a potential storehouse for novel antibiotics.
    Tiwari K; Gupta RK
    Crit Rev Biotechnol; 2012 Jun; 32(2):108-32. PubMed ID: 21619453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biosynthesis of glycopeptide antibiotics--a model for complex, non-ribosomally synthesized, peptidic secondary metabolites.
    Süssmuth RD; Wohlleben W
    Appl Microbiol Biotechnol; 2004 Jan; 63(4):344-50. PubMed ID: 14564489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of molecular biology for the discovery of biosynthetic genes of polyketide and peptide antibiotics produced by actinomycetes].
    Kotowska M
    Postepy Biochem; 2005; 51(3):345-52. PubMed ID: 16381179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and molecular engineering of sugar-containing natural product biosynthetic pathways in actinomycetes.
    Oh TJ; Mo SJ; Yoon YJ; Sohng JK
    J Microbiol Biotechnol; 2007 Dec; 17(12):1909-21. PubMed ID: 18167436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to discover new antibiotics: harvesting the parvome.
    Davies J
    Curr Opin Chem Biol; 2011 Feb; 15(1):5-10. PubMed ID: 21111668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic evidence for antibiotic resistance genes of actinomycetes as origins of antibiotic resistance genes in pathogenic bacteria simply because actinomycetes are more ancestral than pathogenic bacteria.
    Woo PC; Lau SK; Huang Y; Yuen KY
    Med Hypotheses; 2006; 67(6):1297-304. PubMed ID: 16824692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic approaches to antibacterial discovery.
    Payne DJ; Gwynn MN; Holmes DJ; Rosenberg M
    Methods Mol Biol; 2004; 266():231-59. PubMed ID: 15148422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic engineering of antibiotic factories: new tools for antibiotic production in actinomycetes.
    Weber T; Charusanti P; Musiol-Kroll EM; Jiang X; Tong Y; Kim HU; Lee SY
    Trends Biotechnol; 2015 Jan; 33(1):15-26. PubMed ID: 25497361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Glossary for Chemical Approaches towards Unlocking the Trove of Metabolic Treasures in
    Zhang J; Hassan HA; Abdelmohsen UR; Zahran EM
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secondary Metabolites from Marine Microorganisms. I. Secondary Metabolites from Marine Actinomycetes].
    Orlova TI; Bulgakova VG; Polin AN
    Antibiot Khimioter; 2015; 60(7-8):47-59. PubMed ID: 26863742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a natural product library containing secondary metabolites produced by actinomycetes.
    Takagi M; Shin-Ya K
    J Antibiot (Tokyo); 2012 Sep; 65(9):443-7. PubMed ID: 22739538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomics-Driven Natural Product Discovery in Actinomycetes.
    Niu G
    Trends Biotechnol; 2018 Mar; 36(3):238-241. PubMed ID: 29126570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When will the genomics investment pay off for antibacterial discovery?
    Mills SD
    Biochem Pharmacol; 2006 Mar; 71(7):1096-102. PubMed ID: 16387281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic biology of secondary metabolite biosynthesis in actinomycetes: Engineering precursor supply as a way to optimize antibiotic production.
    Wohlleben W; Mast Y; Muth G; Röttgen M; Stegmann E; Weber T
    FEBS Lett; 2012 Jul; 586(15):2171-6. PubMed ID: 22710162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.